No insider purchase over the last 90 days. The latest, by 노문종, was filed 06 Aug 2026.
Key facts
Headquarters: Rockville, United States · Founded: 1999
Source: Wikidata (CC0).
Who traded when
BuySaleSince the insiders bought
- -85.4%Entry ₩108,400 · Close 22 Oct 2026 ₩15,810
- +147.7%Entry ₩17,720 · Close at T+365 ₩43,900
- +18.2%Entry ₩8,010 · Close at T+365 ₩9,470
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 582 sharesShareKRXDART:20260806000446Canonical exit: 4 Nov 2026 (T+90)
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 9,443 shares@ ₩508,325.000.20% mcap7.5% of flowShareKRXDART:20260515002814Canonical exit: 6 Aug 2026 (T+90)
- 118,040 shares@ ₩508,325.002.40% mcap92.5% of flowShareKRXDART:20260330001323Canonical exit: 23 Jun 2026 (T+90)
- 118,040 sharesKRXDART:20260327001489Canonical exit: 23 Jun 2026 (T+90)
- ShareKRXDART:20260306000996
- ShareKRXDART:20240712000278Canonical exit: 3 Oct 2024 (T+90)
- 764,939 sharesKRXDART:20240605000461Canonical exit: 29 Aug 2024 (T+90)
- ShareKRXDART:20240605000484Canonical exit: 29 Aug 2024 (T+90)
- ShareKRXDART:20240605000467Canonical exit: 29 Aug 2024 (T+90)
- 764,939 sharesKRXDART:20230628000516Canonical exit: 26 Sept 2023 (T+90)
- 764,939 sharesKRXDART:20230515001918Canonical exit: 9 Aug 2023 (T+90)
- ShareKRXDART:20230515002026
- ShareKRXDART:20230515001958
- 764,939 sharesKRXDART:20230331003240Canonical exit: 29 Jun 2023 (T+90)
- ShareKRXDART:20220916000456
- ShareKRXDART:20220902000304
- ShareKRXDART:20220902000316
- ShareKRXDART:20220902000309
25 of 31 declarations
About Kolon TissueGene, Inc.
The Kolon TissueGene, Inc. (코오롱티슈진) record, a Korean healthcare company with a market capitalisation of KRW 1,359.2 billion, holds no sale at all. The 14 purchases come mostly from the group: 코오롱, which files 20 of the 24 filings, bought EUR 34,441,540 on March 25, 2026, then EUR 2,808,066 on May 8, 2026. The 3 purchases with an amount total EUR 37.5 million, with a median of EUR 2,808,066. The third, EUR 218,725, is 노문종's, listed as CEO, on March 16, 2022.
The 24 filings, published between December 15, 2021 and August 6, 2026, come from 3 filers. 코오롱생명과학 files 2, both purchases, as does 노문종. 10 filings are of another kind. On May 31, 2024, 2 filers bought on the same day.
Read moreShow less
The year 2022 holds 6 filings, 2023 and 2026 hold 5 each, and 2021 and 2024 hold 4 each. Over the latest twelve months there are 5 filings, 4 of them purchases.
For 13 purchases a 90-day result is stored: a median of -4.5%, with 8% of results positive, to be read as recorded past results and not as a forecast.
